Tecan Group (TCHBF) Stock Price, News & Analysis

Company Overview

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution. It provides PARAMIT, a contract design and manufacturing service. The company operates in Switzerland, Europe, Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.

Key Stats

• Today's Range: $200.00 to $200.00
• 50-Day Range: $182.45 to $202.52
• 52-Week Range: $182.45 to $340.27
• Volume: N/A
• Average Volume: 1,389 shs
• Market Capitalization: N/A
• P/E Ratio: 46.84
• Dividend Yield: 0.75%
• Price Target: N/A
• Consensus Rating: N/A

TCHBF Stock Analysis - Frequently Asked Questions

How have TCHBF shares performed this year?

Tecan Group's stock was trading at $208.03 at the beginning of 2025. Since then, TCHBF shares have decreased by 3.9% and is now trading at $200.00.
View the best growth stocks for 2025 here.

How do I buy shares of Tecan Group?

Shares of TCHBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/25/2025
• Next Earnings (Estimated): 8/12/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:TCHBF
• CIK: N/A
• Web: www.tecan.com
• Phone: (144) 922-8888
• Fax: N/A
• Employees: 3,315
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 46.84
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A